E-191 / WuXi AppTec, Guangdong Zhongsheng Pharma - LARVOL DELTA

Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study. (PubMed, Graefes Arch Clin Exp Ophthalmol) - "Ranibizumab used according to T&E protocol yielded a stronger improvement in logMAR, compared with PRN protocol with longer injection intervals than aflibercept/T&E. This large real-world data assessment supports previous data on the superiority of T&E treatment."

Journal

Older Patients' Views of Health Care Interactions in Ireland. (PubMed, Health Lit Res Pract) - "...2018;2(4):e180-e191.]. This is the first study in Ireland to investigate the link between the communication styles used by health care providers and to what extent older patients felt encouraged to talk about physical, emotional, social, or sensitive health problems. When providers took a more patient-centered approach, these patients felt more encouraged to disclose physical, social, and emotional health problems."

Clinical • Journal